Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10337 - 10344 of 12011 results
President Obama to Sign Executive Order Prohibiting Federal Contractors From Discriminating Against LGBT Employees
June 17, 2014| Blog| Viewpoint
Another Example of Owner Liability for Unpaid Wages and Liquidated Damages for Employee Misclassification
June 17, 2014| Blog| Viewpoint
Department of Energy Invests $20 Million in Hydrogen Production
June 17, 2014| Blog| Viewpoint
Privacy Tuesday - June 17, 2014
June 17, 2014| Blog| Viewpoint
The Affordable Care Act—Countdown to Compliance for Employers, Week 28: The Logic, Calculus, and Limits of “Skinny” Plans
June 16, 2014| Blog| Viewpoint
U.S. Supreme Court: Pom's Mislabeling Suit Against Coke Not Precluded by FDA Regulations
June 13, 2014| Blog| Viewpoint
Proposed Counterfeit Parts Rule Would Expand Coverage to Commercial Products Sold to Any Federal Agency
June 13, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|